Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 24Prostatic Neoplasms 16Sarcoma 9Carcinoma, Non-Small-Cell Lung 9Lung Neoplasms 5Uterine Cervical Neoplasms 4Endometrial Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Liposarcoma, Myxoid 3Head and Neck Neoplasms 3Glioblastoma 3Triple Negative Breast Neoplasms 2Small Cell Lung Carcinoma 2Sarcoma, Synovial 2Radiation Injuries 2Pancreatic Neoplasms 2Neurofibrosarcoma 2Neoplasms 2Melanoma 2Lymphatic Metastasis 2Liposarcoma 2Leiomyosarcoma 2Histiocytoma, Malignant Fibrous 2Fibrosarcoma 2Carcinoma, Intraductal, Noninfiltrating 2Breast Carcinoma In Situ 2Advanced Refractory Solid Tumors 2Uterine Neoplasms 1Urothelial Cancer 1Urogenital Neoplasms 1

Interventions

Leucovorin 2Fluorouracil 2Cetuximab 2Bevacizumab 2spartalizumab 1sintilimab 1Radiotherapy 1Radiation Dose Hypofractionation 1Oxaliplatin 1Irinotecan 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Locally Recurrent Rectal Cancer × Radiation Dose Hypofractionation × Clear all
NCT06928584 2025-04-15

Hypofractionated Radiotherapy Plus Immunotherapy Versus Conventional Radiotherapy in Locally Recurrent Rectal Cancer

Fudan University

Phase 2 Recruiting
221 enrolled
Gastrointestinal

Locally Recurrent Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡